Skip to main content Skip to main navigation menu Skip to site footer
  • Home
  • Current
  • Archives
  • About
    • About the Journal
    • Editorial Board
    • Submissions
    • Journal Policies
  • Our Partners
  • Contact Us
  • Français
  • Login
  1. Home /
  2. Archives /
  3. Volume 1, Issue 1, March 2022

Volume 1, Issue 1, March 2022

					View Volume 1, Issue 1, March 2022
Published: 2022-03-01

Articles

  • Next-generation sequencing for myeloid malignancies Progress and practical applications

    James A. Kennedy, MD, PhD, FRCPC
    8–14
    • PDF (en)
    • PDF (fr)
  • Management of follicular lymphoma at first relapse

    Roopesh Kansara, MD, FRCPC
    16–21
    • PDF (en)
    • PDF (fr)
  • Myeloproliferative neoplasms in 2022 A concise review

    Dawn Maze, MD, MSc, FRCPC
    23–35
    • PDF (en)
    • PDF (fr)
  • Diagnosis and treatment of AL amyloidosis in 2022

    Victor H. Jimenez-Zepeda, MD
    29–35
    • PDF (en)
    • PDF (fr)
  • To transplant or not to transplant in multiple myeloma

    Richard LeBlanc, MD, FRCPC
    37–42
    • PDF (en)
    • PDF (fr)
  • Emerging therapeutic agents in the treatment of relapsed or refractory diffuse large B cell lymphoma

    Anthea Peters, MD, FRCPC
    43–47
    • PDF (en)
    • PDF (fr)
Recent Articles
  • Next-generation sequencing for myeloid malignancies Progress and practical applications
  • Management of follicular lymphoma at first relapse
  • Myeloproliferative neoplasms in 2022 A concise review
  • Diagnosis and treatment of AL amyloidosis in 2022
  • To transplant or not to transplant in multiple myeloma
  • Emerging therapeutic agents in the treatment of relapsed or refractory diffuse large B cell lymphoma

Summary

Journal title
Canadian Hematology Today.
Frequency
3 issues per year (March, June, October)
DOI Prefix
10.58931/cht

Make a Submission

Make a Submission

Open Access

Canadian Hematology Today is an open access journal, which means all its content is freely available without charge. Users are permitted to copy and redistribute the material in any medium or format for any noncommercial purpose, provided they cite the source.

License

© Canadian Hematology Today. Licensed under CC BY-NC-ND 4.0.

 

More information about the publishing system, Platform and Workflow by OJS/PKP.